Hepatic inflammation induced by high-fructose diet is associated with altered 11βHSD1 expression in the liver of Wistar rats

European Journal of Nutrition

Volumn 53, Issue 6, 2014, Pages 1393-1402

  Vasiljević, Ana ^a   Bursać, Biljana ^a   Djordjevic, Ana ^a   Milutinović, Danijela Vojnović ^a   Nikolić, Marina ^a   Matić, Gordana ^a   Veličković, Nataša ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

11 HSD1; Fructose; Glucocorticoids; Inflammation; Liver

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; CORTICOSTERONE; FRUCTOSE; GLUCOCORTICOID; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN RECEPTOR SUBSTRATE 1; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; FATTY ACID; GALACTOSE-6-PHOSPHATE DEHYDROGENASE; GLUCOCORTICOID RECEPTOR; GLUCOSE BLOOD LEVEL; INSULIN RECEPTOR SUBSTRATE; IRS1 PROTEIN, RAT; OXIDOREDUCTASE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALORIC INTAKE; CARBOHYDRATE DIET; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORTICOSTEROID METABOLISM; ENZYME ACTIVATION; HEPATITIS; INSULIN RESISTANCE; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WISTAR RAT; ADIPOSE TISSUE; ANIMAL; BLOOD; BODY WEIGHT; DRUG EFFECTS; ENZYMOLOGY; GENETICS; GLUCOSE BLOOD LEVEL; INFLAMMATION; LIVER; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION;

RATTUS; RATTUS NORVEGICUS;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CARBOHYDRATE DEHYDROGENASES; ENERGY INTAKE; FATTY ACIDS, NONESTERIFIED; FRUCTOSE; GLUCOCORTICOIDS; INFLAMMATION; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; LIVER; MALE; NF-KAPPA B; PHOSPHORYLATION; RATS; RATS, WISTAR; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84906938664     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-013-0641-4     Document Type: Article

References (51)

1. Tappy L, Le KA (2010) Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev 90:23-46. doi:10.1152/physrev.00019.2009
2. Roglans N, Vila L, Farre M, Alegret M, Sanchez RM, Vazquez-Carrera M, Laguna JC (2007) Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in fructose-fed rats. Hepatology 45:778-788. doi:10.1002/hep.21499 (Pubitemid 46450629)
3. Staab CA, Maser E (2010) 11beta-Hydroxysteroid dehydrogenase type 1 is an important regulator at the interface of obesity and inflammation. J Steroid Biochem Mol Biol 119:56-72. doi:10.1016/j.jsbmb.2009.12.013
4. Dekker MJ, Su Q, Baker C, Rutledge AC, Adeli K (2010) Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab 299:E685-E694. doi:10.1152/ajpendo.00283.2010
5. Iwasaki Y, Takayasu S, Nishiyama M, Tsugita M, Taguchi T, Asai M, Yoshida M, Kambayashi M, Hashimoto K (2008) Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene. Mol Cell Endocrinol 285:10-18. doi:10.1016/j.mce. 2008.01.012
6. Wang M (2005) The role of glucocorticoid action in the pathophysiology of the metabolic syndrome. Nutr Metab (Lond) 2:3. doi:10.1186/1743-7075-2-3
7. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM (2004) 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 25:831-866. doi:10.1210/er.2003-0031 (Pubitemid 39366049)
8. Czegle I, Csala M, Mandl J, Benedetti A, Karadi I, Banhegyi G (2012) G6PT-H6PDH-11betaHSD1 triad in the liver and its implication in the pathomechanism of the metabolic syndrome. World J Hepatol 4:129-138. doi:10.4254/wjh.v4.i4.129
9. Rogoff D, Ryder JW, Black K, Yan Z, Burgess SC, McMillan DR, White PC (2007) Abnormalities of glucose homeostasis and the hypothalamic-pituitary- adrenal axis in mice lacking hexose-6-phosphate dehydrogenase. Endocrinology 148:5072-5080. doi:10.1210/en.2007-0593 (Pubitemid 47481507)
10. Nicolaides NC, Galata Z, Kino T, Chrousos GP, Charmandari E (2010) The human glucocorticoid receptor: molecular basis of biologic function. Steroids 75:1-12. doi:10.1016/j.steroids.2009.09.002
11. Stafford JM, Wilkinson JC, Beechem JM, Granner DK (2001) Accessory factors facilitate the binding of glucocorticoid receptor to the phosphoenolpyruvate carboxykinase gene promoter. J Biol Chem 276:39885-39891. doi:10.1074/jbc.M105370200M105370200
12. Yadav H, Jain S, Yadav M, Sinha PR, Prasad GB, Marotta F (2009) Epigenomic derangement of hepatic glucose metabolism by feeding of high fructose diet and its prevention by Rosiglitazone in rats. Dig Liver Dis 41:500-508. doi:10.1016/j.dld.2008.11.012
13. Tsai J, Zhang R, Qiu W, Su Q, Naples M, Adeli K (2009) Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production. Am J Physiol Gastrointest Liver Physiol 296:G1287-G1298. doi:10.1152/ajpgi.90540.2008
14. Rutledge AC, Adeli K (2007) Fructose and the metabolic syndrome: pathophysiology and molecular mechanisms. Nutr Rev 65:S13-S23
15. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11:183-190. doi:10.1038/nm1166 (Pubitemid 40321354)
16. Ghosh S, May MJ, Kopp EB (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225-260. doi:10.1146/annurev.immunol.16.1.225 (Pubitemid 28183365)
17. Solinas G, Karin M (2010) JNK1 and IKKbeta: molecular links between obesity and metabolic dysfunction. FASEB J 24:2596-2611. doi:10.1096/fj.09- 151340
18. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS (2002) A central role for JNK in obesity and insulin resistance. Nature 420:333-336. doi:10.1038/nature01137nature01137 (Pubitemid 35398190)
19. Wei Y, Pagliassotti MJ (2004) Hepatospecific effects of fructose on c-jun NH2-terminal kinase: implications for hepatic insulin resistance. Am J Physiol Endocrinol Metab 287:E926-E933. doi:10.1152/ajpendo.00185.200400185.2004 (Pubitemid 39382929)
20. Kanuri G, Spruss A, Wagnerberger S, Bischoff SC, Bergheim I (2011) Role of tumor necrosis factor alpha (TNFalpha) in the onset of fructose-induced nonalcoholic fatty liver disease in mice. J Nutr Biochem 22:527-534. doi:10.1016/j.jnutbio.2010.04.007
21. Van Bogaert T, De Bosscher K, Libert C (2010) Crosstalk between TNF and glucocorticoid receptor signaling pathways. Cytokine Growth Factor Rev 21:275-286. doi:10.1016/j.cytogfr.2010.04.003
22. Velickovic N, Djordjevic A, Vasiljevic A, Bursac B, Milutinovic DV, Matic G (2013) Tissue-specific regulation of inflammation by macrophage migration inhibitory factor and glucocorticoids in fructose-fed Wistar rats. Br J Nutr 110:456-465. doi:10.1017/S0007114512005193
23. Duncombe WG (1964) The colorimetric micro-determination of non-esterified fatty acids in plasma. Clin Chim Acta 9:122-125
24. Vasiljevic A, Velickovic N, Bursac B, Djordjevic A, Milutinovic DV, Nestorovic N, Matic G (2013) Enhanced prereceptor glucocorticoid metabolism and lipogenesis impair insulin signaling in the liver of fructose-fed rats. J Nutr Biochem 24:1790-1797. doi:10.1016/j.jnutbio.2013.04.001
25. Spector T (1978) Refinement of the coomassie blue method of protein quantitation. A simple and linear spectrophotometric assay for less than or equal to 0.5 to 50 microgram of protein. Anal Biochem 86:142-146
26. Djordjevic A, Vojnovic Milutinovic D, Tanic N, Bursac B, Vasiljevic A, Velickovic N, Elakovic I, Matic G (2012) Identification of suitable reference genes for gene expression studies in tissues from fructose-fed rats. Adv Sci Lett 5:560-565
27. Havel PJ (2005) Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 63:133-157
28. Gross LS, Li L, Ford ES, Liu S (2004) Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment. Am J Clin Nutr 79:774-779 (Pubitemid 41103877)
29. Kelley GL, Allan G, Azhar S (2004) High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation. Endocrinology 145:548-555. doi:10.1210/en.2003-1167en.2003-1167 (Pubitemid 38183796)
30. Kawasaki T, Igarashi K, Koeda T, Sugimoto K, Nakagawa K, Hayashi S, Yamaji R, Inui H, Fukusato T, Yamanouchi T (2009) Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis. J Nutr 139:2067-2071. doi:10.3945/jn.109.105858
31. Lemke U, Krones-Herzig A, Berriel Diaz M, Narvekar P, Ziegler A, Vegiopoulos A, Cato AC, Bohl S, Klingmuller U, Screaton RA, Muller-Decker K, Kersten S, Herzig S (2008) The glucocorticoid receptor controls hepatic dyslipidemia through Hes1. Cell Metab 8:212-223. doi:10.1016/j.cmet.2008.08.001
32. Li G, Hernandez-Ono A, Crooke RM, Graham MJ, Ginsberg HN (2011) Effects of antisense-mediated inhibition of 11betahydroxysteroid dehydrogenase type 1 on hepatic lipid metabolism. J Lipid Res 52:971-981. doi:10.1194/jlr.M013748
33. Bjorntorp P, Rosmond R (2000) Neuroendocrine abnormalities in visceral obesity. Int J Obes Relat Metab Disord 24(Suppl 2):S80-S85 (Pubitemid 30461955)
34. Livingstone DE, Jones GC, Smith K, Jamieson PM, Andrew R, Kenyon CJ, Walker BR (2000) Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 141:560-563 (Pubitemid 32250479)
35. Atanasov AG, Odermatt A (2007) Readjusting the glucocorticoid balance: an opportunity for modulators of 11beta-hydroxysteroid dehydrogenase type 1 activity? Endocr Metab Immune Disord Drug Targets 7:125-140 (Pubitemid 46965221)
36. Paterson JM, Morton NM, Fievet C, Kenyon CJ, Holmes MC, Staels B, Seckl JR, Mullins JJ (2004) Metabolic syndrome without obesity: hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci USA 101:7088-7093. doi:10.1073/pnas.03055241010305524101 (Pubitemid 38596447)
37. Lavery GG, Zielinska AE, Gathercole LL, Hughes B, Semjonous N, Guest P, Saqib K, Sherlock M, Reynolds G, Morgan SA, Tomlinson JW, Walker EA, Rabbitt EH, Stewart PM (2012) Lack of significant metabolic abnormalities in mice with liver-specific disruption of 11beta-hydroxysteroid dehydrogenase type 1. Endocrinology 153:3236-3248. doi:10.1210/en.2012-1019
38. Ignatova ID, Kostadinova RM, Goldring CE, Nawrocki AR, Frey FJ, Frey BM (2009) Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells. Am J Physiol Endocrinol Metab 296:E367-E377. doi:10.1152/ajpendo.90531. 2008
39. Escher G, Galli I, Vishwanath BS, Frey BM, Frey FJ (1997) Tumor necrosis factor alpha and interleukin 1beta enhance the cortisone/cortisol shuttle. J Exp Med 186:189-198 (Pubitemid 27328019)
40. Tomlinson JW, Moore J, Cooper MS, Bujalska I, Shahmanesh M, Burt C, Strain A, Hewison M, Stewart PM (2001) Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. Endocrinology 142:1982-1989 (Pubitemid 32405956)
41. Ishii-Yonemoto T, Masuzaki H, Yasue S, Okada S, Kozuka C, Tanaka T, Noguchi M, Tomita T, Fujikura J, Yamamoto Y, Ebihara K, Hosoda K, Nakao K (2010) Glucocorticoid reamplification within cells intensifies NF-kappaB and MAPK signaling and reinforces inflammation in activated preadipocytes. Am J Physiol Endocrinol Metab 298:E930-E940. doi:10.1152/ajpendo.00320.2009
42. Morton NM, Holmes MC, Fievet C, Staels B, Tailleux A, Mullins JJ, Seckl JR (2001) Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11betahydroxysteroid dehydrogenase type 1 null mice. J Biol Chem 276:41293-41300. doi:10.1074/jbc.M103676200M103676200
43. Seckl JR, Walker BR (2001) Minireview: 11beta-hydroxysteroid dehydrogenase type 1 - a tissue-specific amplifier of glucocorticoid action. Endocrinology 142:1371-1376 (Pubitemid 32299662)
44. Andrew R, Phillips DI, Walker BR (1998) Obesity and gender influence cortisol secretion and metabolism in man. J Clin Endocrinol Metab 83:1806-1809 (Pubitemid 28501063)
45. Livingstone DE, McInnes KJ, Walker BR, Andrew R (2005) Increased A-ring reduction of glucocorticoids in obese Zucker rats: effects of insulin sensitization. Obes Res 13:1523-1526. doi:10.1038/oby.2005.186
46. Lavery GG, Walker EA, Draper N, Jeyasuria P, Marcos J, Shackleton CH, Parker KL, White PC, Stewart PM (2006) Hexose-6-phosphate dehydrogenase knock-out mice lack 11 betahydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation. J Biol Chem 281:6546-6551. doi:10.1074/jbc.M512635200 (Pubitemid 43847588)
47. Bursac BN, Djordjevic AD, Vasiljevic AD, Milutinovic DD, Velickovic NA, Nestorovic NM, Matic GM (2013) Fructose consumption enhances glucocorticoid action in rat visceral adipose tissue. J Nutr Biochem 24:1166-1172. doi:10.1016/j.jnutbio.2012.09.002
48. Lumeng CN, Saltiel AR (2011) Inflammatory links between obesity and metabolic disease. J Clin Invest 121:2111-2117. doi:10.1172/JCI57132
49. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M (2005) IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11:191-198. doi:10.1038/nm1185 (Pubitemid 40321355)
50. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesitylinked insulin resistance. Science 259:87-91 (Pubitemid 23036092)
51. Boden G, She P, Mozzoli M, Cheung P, Gumireddy K, Reddy P, Xiang X, Luo Z, Ruderman N (2005) Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. Diabetes 54:3458-3465 (Pubitemid 43334336)